Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma.

ABSTRACT: Advanced renal cell carcinoma is a biologically heterogeneous disease with multiple treatment options that largely involve immunotherapy and/or anti-angiogenic therapies. The choice of initial and subsequent therapy depends on both clinical and biological considerations. Here, we describe the application of recent data to clinical practice.

SUBMITTER: Rini BI 

PROVIDER: S-EPMC10008164 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature